Growth Metrics

Innoviva (INVA) Enterprise Value Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.17%
Dec 31, 2025 -23.70%
Sep 30, 2025 -16.54%
Jun 30, 2025 -11.92%
Mar 31, 2025 -13.75%
Dec 31, 2024 -50.01%
Sep 30, 2024 -78.12%
Jun 30, 2024 -131.98%
Mar 31, 2024 6.85%
Dec 31, 2023 -2.72%
Sep 30, 2023 25.19%
Jun 30, 2023 23.15%
Mar 31, 2023 26.15%
Dec 31, 2022 3.33%
Sep 30, 2022 -2.39%
Jun 30, 2022 -7.29%
Mar 31, 2022 -6.30%
Dec 31, 2021 6.20%
Sep 30, 2021 4.16%
Jun 30, 2021 29.98%
Mar 31, 2021 -58.28%
Dec 31, 2020 -11.47%
Sep 30, 2020 -36.72%
Jun 30, 2020 -41.13%
Mar 31, 2020 -28.18%
Dec 31, 2019 -28.91%
Sep 30, 2019 -23.48%
Jun 30, 2019 -14.28%
Mar 31, 2019 -2.38%
Dec 31, 2018 16.40%
Sep 30, 2018 36.66%
Jun 30, 2018 22.78%
Mar 31, 2018 39.49%
Dec 31, 2017 18.77%
Sep 30, 2017 13.86%
Jun 30, 2017 25.98%
Mar 31, 2017 22.93%
Dec 31, 2016 31.36%
Sep 30, 2016 33.48%
Jun 30, 2016 29.71%
Mar 31, 2016 28.44%
Dec 31, 2015 9.00%
Sep 30, 2015 8.98%
Jun 30, 2015 8.11%
Mar 31, 2015 -7.86%
Dec 31, 2014 0.06%
Sep 30, 2014 0.26%
Jun 30, 2014 -5.62%
Mar 31, 2014 -35.87%
Dec 31, 2013 -14.53%
Sep 30, 2013 -100.18%
Jun 30, 2013 -85.22%
Dec 31, 2012 -73.54%